Home LiteratureArticle Details
PMID: 20161740 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.

PloS one ·Vol. 5 ·No. 2 ·2010-02-09 ·Pages e9126

Becquart P, Wauquier N, Mahlakõiv T, Nkoghe D, Padilla C, Souris M, Ollomo B, Gonzalez JP, De Lamballerie X, Kazanji M, Leroy EM

Abstract

To better understand Zaire ebolavirus (ZEBOV) circulation and transmission to humans, we conducted a large serological survey of rural populations in Gabon, a country characterized by both epidemic and non epidemic regions. The survey lasted three years and covered 4,349 individuals from 220 randomly selected villages, representing 10.7% of all villages in Gabon. Using a sensitive and specific ELISA method, we found a ZEBOV-specific IgG seroprevalence of 15.3% overall, the highest ever reported. The seroprevalence rate was significantly higher in forested areas (19.4%) than in other ecosystems, namely grassland (12.4%), savannah (10.5%), and lakeland (2.7%). No other risk factors for seropositivity were found. The specificity of anti-ZEBOV IgG was confirmed by Western blot in 138 individuals, and CD8 T cells from seven IgG+ individuals were shown to produce IFN-gamma after ZEBOV stimulation. Together, these findings show that a large fraction of the human population living in forested areas of Gabon has both humoral and cellular immunity to ZEBOV. In the absence of identified risk factors, the high prevalence of "immune" persons suggests a common source of human exposure such as fruits contaminated by bat saliva. These findings provide significant new insights into ZEBOV circulation and human exposure, and raise important questions as to the human pathogenicity of ZEBOV and the existence of natural protective immunization.

MeSH Terms
Adolescent Adult Age Factors Antibodies, Viral/blood Child Child, Preschool Ebolavirus/immunology Enzyme-Linked Immunosorbent Assay Female Gabon/epidemiology Geography Hemorrhagic Fever, Ebola/epidemiology,immunology,virology Humans Immunity, Cellular/immunology Immunity, Humoral/immunology Immunoglobulin G/blood Infant Interferon-gamma/metabolism Male Middle Aged Prevalence Rural Population/statistics & numerical data Seroepidemiologic Studies T-Lymphocytes/immunology,metabolism Young Adult
Chemicals
Antibodies, Viral Immunoglobulin G Interferon-gamma
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Becquart Pierre
Unité des Maladies Virales Emergentes, Centre International de Recherches Médicales de Franceville, Franceville, Gabon.
Wauquier Nadia
Mahlakõiv Tanel
Nkoghe Dieudonné
Padilla Cindy
Souris Marc
Ollomo Benjamin
Gonzalez Jean-Paul
De Lamballerie Xavier
Kazanji Mirdad
Leroy Eric M
References (53)
53 references, click to expand
  1. Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.
    PLoS One. 2009;4(4):e5308 PMID: 19390586
  2. Multiple Ebola virus transmission events and rapid decline of central African wildlife.
    Science. 2004 Jan 16;303(5656):387-90 PMID: 14726594
  3. Isolation and partial characterisation of a new strain of Ebola virus.
    Lancet. 1995 May 20;345(8960):1271-4 PMID: 7746057
  4. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.
    Nat Med. 1999 Apr;5(4):423-6 PMID: 10202932
  5. Catastrophic ape decline in western equatorial Africa.
    Nature. 2003 Apr 10;422(6932):611-4 PMID: 12679788
  6. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation.
    Nat Immunol. 2001 May;2(5):423-9 PMID: 11323696
  7. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
    Nat Med. 2005 Jul;11(7):786-90 PMID: 15937495
  8. Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses.
    PLoS One. 2009;4(5):e5547 PMID: 19440245
  9. Duration of antiviral immunity after smallpox vaccination.
    Nat Med. 2003 Sep;9(9):1131-7 PMID: 12925846
  10. Preferential localization of effector memory cells in nonlymphoid tissue.
    Science. 2001 Mar 23;291(5512):2413-7 PMID: 11264538
  11. Marburg virus infection detected in a common African bat.
    PLoS One. 2007 Aug 22;2(8):e764 PMID: 17712412
  12. Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins.
    J Virol. 2005 Nov;79(22):14189-96 PMID: 16254354
  13. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooué-Ivindo region, Northeastern Gabon, 1997.
    J Infect Dis. 2005 Mar 15;191(6):964-8 PMID: 15717273
  14. Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection.
    J Immunol. 2005 Jul 15;175(2):1184-91 PMID: 16002721
  15. Plaque assay for Ebola virus.
    J Clin Microbiol. 1981 Apr;13(4):791-3 PMID: 7014628
  16. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection.
    Immunity. 2007 Sep;27(3):393-405 PMID: 17892848
  17. Ebola haemorrhagic fever in Zaire, 1976.
    Bull World Health Organ. 1978;56(2):271-93 PMID: 307456
  18. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda.
    PLoS Pathog. 2008 Nov;4(11):e1000212 PMID: 19023410
  19. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues.
    J Infect Dis. 1999 Feb;179 Suppl 1:S65-75 PMID: 9988167
  20. An outbreak of Ebola in Uganda.
    Trop Med Int Health. 2002 Dec;7(12):1068-75 PMID: 12460399
  21. Studies of reservoir hosts for Marburg virus.
    Emerg Infect Dis. 2007 Dec;13(12):1847-51 PMID: 18258034
  22. Fruit bats as reservoirs of Ebola virus.
    Nature. 2005 Dec 1;438(7068):575-6 PMID: 16319873
  23. Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations.
    Res Virol. 1989 Jul-Aug;140(4):319-31 PMID: 2505350
  24. Isolation of Nipah virus from Malaysian Island flying-foxes.
    Microbes Infect. 2002 Feb;4(2):145-51 PMID: 11880045
  25. Generation and maintenance of immunological memory.
    Semin Immunol. 2004 Oct;16(5):323-33 PMID: 15528077
  26. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995.
    J Infect Dis. 1999 Feb;179 Suppl 1:S102-7 PMID: 9988172
  27. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007.
    Vector Borne Zoonotic Dis. 2009 Dec;9(6):723-8 PMID: 19323614
  28. The natural history of Hendra and Nipah viruses.
    Microbes Infect. 2001 Apr;3(4):307-14 PMID: 11334748
  29. Ebola virus infection in man: a serological and epidemiological survey in the Cameroons.
    Am J Trop Med Hyg. 1983 Nov;32(6):1465-6 PMID: 6650749
  30. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué.
    Trans R Soc Trop Med Hyg. 1982;76(6):719-20 PMID: 7164137
  31. Discovery of swine as a host for the Reston ebolavirus.
    Science. 2009 Jul 10;325(5937):204-6 PMID: 19590002
  32. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells.
    Science. 2000 Oct 6;290(5489):92-7 PMID: 11021806
  33. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread.
    Bull World Health Organ. 1983;61(6):997-1003 PMID: 6370486
  34. Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001.
    MMWR Morb Mortal Wkly Rep. 2001 Feb 9;50(5):73-7 PMID: 11686289
  35. Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States.
    J Infect Dis. 1999 Feb;179 Suppl 1:S108-14 PMID: 9988173
  36. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein.
    J Virol. 2001 Mar;75(6):2660-4 PMID: 11222689
  37. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats.
    PLoS Pathog. 2009 Jul;5(7):e1000536 PMID: 19649327
  38. Seasonal variation in antibodies against Ebola virus in Kenyan fever patients.
    Lancet. 1986 May 17;1(8490):1160 PMID: 2871413
  39. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team.
    Bull World Health Organ. 1978;56(2):247-70 PMID: 307455
  40. CD8 T cell responses to viral infections in sequence.
    Cell Microbiol. 2004 May;6(5):411-21 PMID: 15056212
  41. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.
    J Infect Dis. 1999 Feb;179 Suppl 1:S76-86 PMID: 9988168
  42. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
    Nature. 2003 Aug 7;424(6949):681-4 PMID: 12904795
  43. Ebola outbreak killed 5000 gorillas.
    Science. 2006 Dec 8;314(5805):1564 PMID: 17158318
  44. Human asymptomatic Ebola infection and strong inflammatory response.
    Lancet. 2000 Jun 24;355(9222):2210-5 PMID: 10881895
  45. Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic.
    Microbes Infect. 2000 Jan;2(1):39-44 PMID: 10717539
  46. Immunity and immunological memory following smallpox vaccination.
    Immunol Rev. 2006 Jun;211:320-37 PMID: 16824139
  47. Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants.
    Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17123-7 PMID: 17942693
  48. Preliminary report: isolation of Ebola virus from monkeys imported to USA.
    Lancet. 1990 Mar 3;335(8688):502-5 PMID: 1968529
  49. ELISA for the detection of antibodies to Ebola viruses.
    J Infect Dis. 1999 Feb;179 Suppl 1:S192-8 PMID: 9988184
  50. Effector and memory T-cell differentiation: implications for vaccine development.
    Nat Rev Immunol. 2002 Apr;2(4):251-62 PMID: 12001996
  51. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans.
    J Exp Med. 2004 Jun 7;199(11):1585-93 PMID: 15184506
  52. Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species.
    J Infect Dis. 2007 Nov 15;196 Suppl 2:S176-83 PMID: 17940947
  53. Filovirus activity among selected ethnic groups inhabiting the tropical forest of equatorial Africa.
    Trans R Soc Trop Med Hyg. 1993 Sep-Oct;87(5):536-8 PMID: 8266403
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2010-02-09
Epub
2010-00-09
Pages
e9126
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC2817732
Subset
IM
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com